Rational contraception: minimizing the risks

Rational contraception: minimizing the risks

The use of COCs, even low - and microdosed should be based on an individual assessment of the risk of thrombotic complications. It is advisable to combine the COC together with multivitamin complexes that affect the hemostatic system in the first place, vascular endothelial component (Duovit® for wo...

Full description

Bibliographic Details
Main Authors:	P A Kiryushchenkov, M A Tambovtseva
Format:	Article
Language:	Russian
Published:	IP Berlin A.V. 2015-04-01
Series:	Гинекология
Subjects:	hormonal contraception risk factors venous thromboembolism multivitamin complexes
Online Access:	https://gynecology.orscience.ru/2079-5831/article/viewFile/28423/pdf

Similar Items

Hormonal contraception and the risk of venous thrombosis: Management recommendations from the Piedmont Region and the Consensus Conference of the Italian National Institute of Health
by: Valentina Donvito, et al.
Published: (2013-04-01)

Noncontraceptive effects of combined oral contraceptives: benefits and risks of use
by: A L Unanyan, et al.
Published: (2017-04-01)

A Multi-Institutional Informed Consent Proposal as a Prevention Tool for Combined Oral Contraceptive Intake and Thrombotic Risk
by: Marina Vinciguerra, et al.
Published: (2023-03-01)

Obesity and contraceptive use: impact on cardiovascular risk
by: Giuseppe M.C. Rosano, et al.
Published: (2022-12-01)

Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk
by: Laure Morimont, et al.
Published: (2021-12-01)

Comparison of risks of thromboembolism of drospirenone-containing and nondrospirenone -containing combined oral contraceptive use: A meta-analysis
by: Wan-Lin Zhang, et al.
Published: (2021-01-01)

Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report
by: Maxime G. Zermatten, et al.
Published: (2020-03-01)

Attitudes of women towards products containing hormones (hormonal contraceptives or hormone therapy): what changes from pre to postmenopause?
by: Giovanni Grandi, et al.
Published: (2021-01-01)

Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings
by: Małgorzata Bińkowska, et al.
Published: (2022-10-01)

Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
by: Sebastião Freitas de Medeiros
Published: (2017-12-01)

Selected effects of combined oral contraceptives use
by: Julia Bogucka, et al.
Published: (2022-08-01)

Risks of venous thromboembolic complications in related to combined oral contraceptives
by: K. A. Gabelova, et al.
Published: (2022-01-01)

An oral combined contraceptive user with elevated D-dimer post COVID-19: a case report
by: Nada A. Alyousefi
Published: (2021-08-01)

Complex questions about combined hormonal contraception: A review
by: Vera N. Prilepskaya, et al.
Published: (2023-07-01)

Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience
by: Yong-Su Jang, et al.
Published: (2021-07-01)

The Risk of Venous Thromboembolism with Different Generation of Oral Contraceptives; a Systematic Review and Meta-Analysis
by: Alireza Baratloo, et al.
Published: (2018-11-01)

Hormonal Contraceptive Treatment May Reduce the Risk of Fibromyalgia in Women with Dysmenorrhea: A Cohort Study
by: Cheng-Hao Tu, et al.
Published: (2020-12-01)

Oxidative Stress Is Increased in Combined Oral Contraceptives Users and Is Positively Associated with High-Sensitivity C-Reactive Protein
by: Sabina Cauci, et al.
Published: (2021-02-01)

Hormonal contraceptives and cerebral venous thrombosis risk: A systematic review and meta-analysis
by: Farnaz eAmoozegar, et al.
Published: (2015-02-01)

Oral contraceptive and acute intestinal ischemia with mesenteric venous thrombosis: a case report
by: Béliard A, et al.
Published: (2017-01-01)

Hemostasis and female sex hormones
by: О. А. Ефименко, et al.
Published: (2018-02-01)

Risk Factors, Prophylaxis, and Treatment of Venous Thromboembolism in Congenital Heart Disease Patients
by: Michael Silvey, et al.
Published: (2017-06-01)

Risk factors for venous thromboembolism in a single pediatric intensive care unit in China
by: Jintuo Zhou, et al.
Published: (2024-03-01)

Cerebral venous thrombosis following the use of oral contraceptive: a case report
by: Mehrafza Mir, et al.
Published: (2016-12-01)

Cerebral venous thrombosis following the use of oral contraceptive: a case report
by: Mehrafza Mir, et al.
Published: (2016-12-01)

OVERCOME BARRIERS IN PRESCRIPTION OF HORMONAL CONTRACEPTION (CLINICAL LECTURE)
by: O. A. Pustotina, et al.
Published: (2016-12-01)

Risk factors for venous thromboses in patients with rheumatoid arthritis
by: M. A. Satybaldyeva, et al.
Published: (2019-01-01)

Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt
by: Goubran Hadi A, et al.
Published: (2012-09-01)

Risk factors for venous thromboembolic events in patients with rheumatoid arthritis
by: M. A. Satybaldyeva, et al.
Published: (2016-10-01)

Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study
by: Daniela Tormene, et al.
Published: (2022-11-01)

Dyslipidemia and associated factors among women using hormonal contraceptives in Harar town, Eastern Ethiopia
by: Berhanu Sufa, et al.
Published: (2019-03-01)

Comparison of risk assessments for venous thromboembolism during the puerperium
by: Xianggui Luo, et al.
Published: (2023-02-01)

Analysis of risk factors for venous thromboembolism in 76 patients with acute leukemia
by: Er-qing Yang, et al.
Published: (2023-08-01)

Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis
by: Luz Angela Torres-de la Roche, et al.
Published: (2023-11-01)

Male contraception
by: Vivek Mathew, et al.
Published: (2012-01-01)

Comments on 'Analysis of risk factors for venous thromboembolism in 76 patients with acute leukemia'
by: Ying Luo, et al.
Published: (2023-09-01)

Risk factors associated with venous thromboembolism in tuberculosis: A case control study
by: Guo Yi Nan, et al.
Published: (2022-12-01)

Menopausal hormone therapy: a course to improve the effectiveness
by: A L Unanyan, et al.
Published: (2017-10-01)

Confounding factors of primary venous thromboses and embolisms associated with reproductive behavior of women
by: T E Belokrinitskaya, et al.
Published: (2016-04-01)

Risk Factors of Unfavorable Outcomes, Major Bleeding, and All-Cause Mortality in Patients with Venous Thromboembolism
by: Han Young Lee, et al.
Published: (2021-12-01)